Depression News and Research

Latest Depression News and Research

Patients who survived life-threatening illness in ICU at increased risk for psychiatric symptoms

Results of a multi-institutional national study of nearly 700 people who survived life-threatening illness with a stay in an intensive care unit (ICU) suggest that a substantial majority of them are at high risk for persistent depression, anxiety and post-traumatic stress disorder — especially if they are female, young and unemployed.

21 Apr 2016

Non-invasive optogenetic therapy can help treat chronic pain

The potential of light as a non-invasive, highly-focused alternative to pain medication was made more apparent thanks to research conducted by scientists at the Montreal Neurological Institute and Hospital of McGill University and the McGill University Health Centre.

21 Apr 2016

Savouring positive memories can boost mood in individuals with mental health problems

Researchers from the University of Liverpool have published a study highlighting the effectiveness of using positive memories and images to help generate positive emotions.

21 Apr 2016

Expanded Medicaid coverage shows increase in health insurance rates among low-income adults

Researchers at UCLA have that found states that expanded Medicaid coverage under the Affordable Care Act saw a significant increase in rates of health insurance among low-income adults compared with states that did not expand the program.

20 Apr 2016

Researchers evaluate TBI-associated risk factors in older adults

Traumatic brain injury (TBI), a leading cause of death and disability, has become so common in recent times that it has been called a "silent epidemic." And because older adults are more likely to suffer TBI, have worse outcomes, and are less likely to survive their injury than younger adults, older adults are considered a "silent population" within this epidemic.

20 Apr 2016

Small piece of detoxified E. coli wall makes mice lose natural sweet tooth, study finds

Putting just a tiny piece of the wall of detoxified E. coli into their gut make mice lose their natural sweet tooth, researchers report.

20 Apr 2016

Psilocybin administration reduces reaction to social rejection in associated brain areas

Social ties are vital for mental and physical health. However, psychiatric patients in particular frequently encounter social exclusion and rejection. Furthermore, psychiatric patients often react more strongly to social rejection than healthy persons and this can have negative consequences for the development and treatment of psychiatric disorders.

19 Apr 2016

Reducing hair loss during chemotherapy: an interview with Richard Paxman

The basic principle of chemotherapy is to damage the mitotic and metabolic processes in the cancer cells. The chemotherapy doesn't just target the cancer cells, it also targets the healthy cells, specifically ones that are rapidly dividing - our hair follicles are also rapidly dividing. We see damage to those hair cells, which then causes the hair to fall out.

From Paxman 19 Apr 2016

More than half of U.S. adults believe today's kids have diminished emotional and mental health

More than half of adults believe children today are more stressed, experience less quality family time and have worse mental and emotional health than children in past generations, according to the C.S. Mott Children's Hospital National Poll on Children's Health.

18 Apr 2016

Researchers find that children develop self-control mechanisms by age 3

University of Texas at Arlington researchers have found that by age 3 environmental influences such as parenting are relevant factors in the development of toddlers' self-control when they are asked not to do something they want to do, such as run into the street or eat a forbidden snack.

16 Apr 2016

Heavy marijuana use may lead to lower dopamine release in the brain

In a recent study, researchers found evidence of a compromised dopamine system in heavy users of marijuana. Lower dopamine release was found in the striatum - a region of the brain that is involved in working memory, impulsive behavior, and attention. Previous studies have shown that addiction to other drugs of abuse, such as cocaine and heroin, have similar effects on dopamine release, but such evidence for cannabis was missing until now.

16 Apr 2016

Experts launch mhNOW initiative to bring proven mental health solutions to people most in need

Today, the Mental Health Now, or mhNOW, initiative will launch at the inaugural Financing and Innovation in Global Health (FIGH) conference. Led by mental health experts Chris Underhill, founder and president of BasicNeeds, and Moitreyee Sinha, head of health at the Global Development Incubator (GDI), mhNOW is a global, collective action including social entrepreneurs, organizations and companies that are working together to innovate and identify mental health solutions on a global scale, and systemically implement in communities at a local level.

15 Apr 2016

New classifier method may improve diagnosis of autism spectrum disorders

Many doctors and scientists think they could improve the diagnosis and understanding of autism spectrum disorders if they had reliable means to identify specific abnormalities in the brain.

15 Apr 2016

Innate Immunotherapeutics announces clinical trial fully enrolled and receives strong interest from potential Pharma partners

Innate Immunotherapeutics Limited has closed enrolment into the Company's Phase 2B placebo controlled efficacy trial of MIS416 in patients with secondary progressive multiple sclerosis (SPMS). The study has exceeded the original recruitment target of 90 subjects with the successful enrolment this week of the 93rd patient.

14 Apr 2016

National plan outlines milestones, strategies for Alzheimer's patient care and caregiver support

The National Alzheimer's Project Act (NAPA) was signed into law in 2011. Over the past five years milestones have been identified to meet the plan's biomedical research goal. However, similar milestones have not been created for the goals on patient care and caregiver support.

13 Apr 2016

Depression combined with behavioral, metabolic symptoms increases risk of type 2 diabetes

Depression may compound the risk of developing type 2 diabetes in people with such early warning signs of metabolic disease as obesity, high blood pressure and unhealthy cholesterol levels, according to researchers from McGill University, l'Université de Montréal, the Institut de recherches cliniques de Montréal and the University of Calgary.

13 Apr 2016

Depression News and Research

Latest Depression News and Research

Patients who survived life-threatening illness in ICU at increased risk for psychiatric symptoms

Non-invasive optogenetic therapy can help treat chronic pain

Savouring positive memories can boost mood in individuals with mental health problems

Expanded Medicaid coverage shows increase in health insurance rates among low-income adults

Researchers evaluate TBI-associated risk factors in older adults

Small piece of detoxified E. coli wall makes mice lose natural sweet tooth, study finds

Psilocybin administration reduces reaction to social rejection in associated brain areas

Reducing hair loss during chemotherapy: an interview with Richard Paxman

More than half of U.S. adults believe today's kids have diminished emotional and mental health

Researchers find that children develop self-control mechanisms by age 3

Heavy marijuana use may lead to lower dopamine release in the brain

Experts launch mhNOW initiative to bring proven mental health solutions to people most in need

New classifier method may improve diagnosis of autism spectrum disorders

Innate Immunotherapeutics announces clinical trial fully enrolled and receives strong interest from potential Pharma partners

National plan outlines milestones, strategies for Alzheimer's patient care and caregiver support

Depression combined with behavioral, metabolic symptoms increases risk of type 2 diabetes

Researchers analyze post-Ebola syndrome survivors to improve ongoing treatment

New data from studies evaluating diagnostic tools, therapies for infectious diseases released at ECCMID 2016

Long-term medication use reduces risk of relapse and improves symptoms in BDD patients

Parent, provider partnership benefits child's development during transition from home to non-parental care

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Depression News and Research

Latest Depression News and Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in